Teva Pharmaceutical Industries Ltd has announced the launch of the #Laugh4Lungs campaign. This social media campaign aims to use the power of laughter to promote global awareness of chronic obstructive pulmonary disease (COPD) and to raise money for three leading COPD charities across Europe, including: the British Lung Foundation (UK), Longfonds (Netherlands) and Fundación Lovexair (Spain).
#Laugh4Lungs is being launched in recognition of World COPD Day, which takes place on 18 November 2015.
COPD is a debilitating lung disease that is estimated to affect more than 200 million people worldwide. Although COPD represents the fourth most common cause of death globally, awareness of COPD among the general public and those at greatest risk for the disease remains surprisingly low. As such, it is likely that many more individuals are living with COPD, but are yet to be diagnosed.
“At Teva we believe it is important to increase global awareness of this debilitating disease,” said Luca Frangoni, Head of Respiratory, Teva Europe. “With #Laugh4Lungs we have chosen laughter as the vehicle to promote awareness of COPD because it’s a universal language that transcends between all ages and is beneficial for lung function and overall well-being.”
#Laugh4Lungs aims to inspire people to use the power of laughter to raise awareness and money for COPD, and to remind those living with COPD that they aren’t alone. The campaign encourages people to share videos of themselves or someone else laughing on social media channels, then tag or nominate others within their social networks. In addition, people can also donate money to charities that are working to make a difference within the COPD community.
Please visit www.ICanLiveWithCOPD.com for more information about #Laugh4Lungs and how to donate, as well as further resources and practical advice about living with COPD.